Skip to main content
. 2020 Sep 21;10(9):730. doi: 10.3390/diagnostics10090730

Table 2.

Overview of the rating results in terms of the prognostic significance.

Mean Bud Count Bd1 1 Bd2 1 Bd3 1 p
H & E 1 CK
0.785 mm2 0.785 mm2 n % n % n %
Rcons (sCK) 164 43 22
Death 60 37% 21 49% 12 55% 0.22
Cancer-specific death 17 10% 5 12% 5 23% 0.26
Distant metastasis 27 16% 10 23% 7 32% 0.15
Investigator 1 4.9 ± 5.8 11.2 ± 13.5 144 29 56
Death 56 39% 13 45% 24 43% 0.72
Cancer-specific death 12 8% 5 17% 10 18% 0.22
Distant metastasis 21 15% 6 21% 17 30% 0.15/0.05 *
Investigator 2 2.9 ± 3.1 7.0 ± 5.7 154 52 23
Death 64 42% 17 33% 12 52% 0.20
Cancer-specific death 17 11% 4 8% 6 26% 0.02
Distant metastasis 31 20% 6 12% 7 30% 0.13/0.04 °
Investigator 3 2.8 ± 3.4 6.6 ± 6.7 176 48 5
Death 62 35% 29 60% 2 40% 0.01
Cancer-specific death 19 11% 7 15% 1 20% 0.48
Distant metastasis 28 16% 16 33% 0 0% 0.01
Investigator 5 4.1 ± 4.4 11.1 ± 7.5 138 59 32
Death 50 36% 28 47% 15 47% 0.51
Cancer-specific death 10 7% 10 17% 7 22% 0.05
Distant metastasis 21 15% 11 19% 12 38% 0.01
Investigator 6 2.7 ± 2.9 7.7 ± 5.8 167 48 14
Death 68 41% 19 40% 6 43% 0.94
Cancer-specific death 18 11% 8 17% 1 7% 0.43
Distant metastasis 32 19% 10 21% 2 14% 0.71
Investigator 7 4.2 ± 9.5 10.1 ± 13.9 162 30 37
Death 61 38% 15 50% 17 46% 0.30
Cancer-specific death 16 10% 6 20% 5 14% 0.18
Distant metastasis 28 17% 9 30% 7 19% 0.19

1 the bud counting for bd grading was performed on H & E; a cytokeratin staining was available as support for the identification of buds; p: values for Kaplan–Meier analyses; pairwise comparisons: * Bd1 vs. Bd3 p = 0.049; ° Bd2 vs. Bd3 p = 0.042. The bold numbers are statistically significant.